Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist
- 15 July 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 332 (4) , 927-933
- https://doi.org/10.1016/j.bbrc.2005.05.065
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialThe Lancet, 2004
- Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatmentDiabetologia, 2003
- Pancreatic β-Cells Express Phagocyte-Like NAD(P)H OxidaseDiabetes, 2003
- Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucoseKidney International, 2002
- Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patientsDiabetologia, 2002
- Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidantsProceedings of the National Academy of Sciences, 1999
- Angiotensin II induces superoxide anion production by mesangial cellsKidney International, 1998
- Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.Circulation Research, 1994
- Hyperglycemic Pseudohypoxia and Diabetic ComplicationsDiabetes, 1993
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988